If it is decided that the required ailments are achieved, future, Examine the dealing with standing / inventory standing of prescription drugs versus many insurance coverage pharmacies near the deal with in the medical institution / insurer, and obtain the outcome. Also produce to professional medical establishments. Conversely, if it is decided that the required ailments will not be satisfied, the prescription recommendation matter derived dependant on the insured human being's information presented from the clinical establishment inside a variety that matches the desired circumstances on the examination payer plus the insurer Distribute an index of medicines to clinical institutions and stimulate them to reselect.
During the pharmaceutical prescription information inquiry / distribution procedure In line with claim 1, if the result of determination would be that the inquiry content material doesn't conform to the enter information and designated problems in the assessment and payment establishment and also the insurance provider, research and determine the pharmaceutical team that satisfies these Pharmaceutical prescription information inquiry / distribution program characterized by distribution to clinical institutions.
Complete the shape and after that click the containers to indicate the kind of information you would like to acquire.
以下に、図４を用いて情報照会・判定の手順の一例のフローチャートを説明する。まず審査支払機関・保険者・保険医療機関・保険薬局から必要な情報を取得する。審査支払機関及び保険者から取得する情報・指定条件は前述の通りであり、医療機関・保険薬局からは所在地等の基本情報に加え、使用希望薬剤情報・医薬品取扱情報・同在庫情報等を取得し、取得したデータを格納する。
請求項１に記載の医薬品処方情報照会・配信システムにおいて、医療機関が発行した処方箋に記されている医薬品の保険適用につき、保険薬局からの照会を受付け、処方箋発行医療機関との照会履歴の有無、結果について配信することを特徴とする医薬品処方情報照会・配信システム。
The pharmaceutical prescription information inquiry / distribution program In line with claim one, wherein a series of inquiry histories made by means of the program is dispersed to an evaluation payment Business and an insurance provider.
Hereinafter, a flowchart of an illustration of an information inquiry / willpower method might be explained with reference to FIG. Initially, the required information is acquired in the assessment payer / insurance company / insurance policy healthcare establishment / insurance policy pharmacy. The information and selected problems being received from the evaluation payer plus the insurance provider are as explained previously mentioned.
そして個々の診療行為毎に医療機関から医薬品処方につき照会を受けると、照会時に医療機関から提示される被保険者情報（医療保険関連情報、傷病・症状等の情報等）と、予め取得した情報とを照合し、被保険者が加入している保険者並びに担当の審査支払機関の指定条件を満たしているか否かをリアルタイムで判定する。
And when you receive an inquiry about health care prescriptions from a health care establishment for every particular person clinical observe, insured human being information (clinical coverage similar information, information on sickness / indications, etcetera.
Because of this, although maintaining the fairness of obtaining health care solutions, the insured / insurance provider / examination / payment establishment has the opportunity to pick out a drug that is certainly considered desirable through the viewpoint of success, price, and so forth. Is not really presented enough. For that reason, the challenge of the existing creation would be that the insured person / insurance company or evaluation / payment establishment hopes to prescribe the strongest prescription among the solutions even though retaining the fairness of acquiring healthcare providers in Japan's healthcare insurance policy technique.
In essential conditions, the prescription is a little paper and that is published with the registered health treatment practitioner (RMP) determined by the consumer's ailment issue.
During the method operation phase, the subsequent processing is executed in actual time. Basically, inquiries regarding The provision of insurance coverage coverage for prescription drugs from health care institutions are created via communication lines in read more the course of Every professional medical observe, and these inquiries are compared Using the input information and specified disorders of your assessment and payment establishments and insurers talked about over. Then, the assessment spending institution as well as the insurer identify whether to reject the insurance policy software, distribute the result to the clinical institution, and Display screen it to the terminal in the medical institution by an input / output monitor as proven in FIG. On account of the dedication, Should the articles of the inquiry isn't going to conform to the input information and specified disorders in the examination and payment institution along with the insurer, a pharmaceutical group enjoyable these is searched and determined and distributed on the medical institution.
Consider therapy modification - knowledge exhibit that the desired agents may connect with one another in the clinically-important method and patient-particular evaluation need to be conducted to ascertain irrespective of whether the advantages of concomitant therapy outweigh the risks. Precise steps need to be taken in order to comprehend the advantages and/or minimize toxicity of concomitant use. Stay clear of mixture - data exhibit that the required agents may perhaps interact with one another in the clinically-sizeable method and the chance typically outweighs any likely profit. Concurrent use of these agents is mostly considered contraindicated. Exam Interactions - Listing of assay interferences when applicable
請求項１に記載の医薬品処方情報照会・配信システムにおいて、医療機関から診療行為毎に照会される処方医薬品が、保険者・審査支払機関の指定条件を満たす場合、医療機関や被保険者の住所の近くに存在する保険薬局数軒での当該医薬品の取扱情報・在庫情報を保険薬局のデータベースにアクセスし確認を行うことを特徴とする医薬品処方情報照会・配信システム。